8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Mar 18, 2026·SEC
Material company update
Mar 9, 2026·SEC
LifeMD, Inc.(LFMD)Earnings, Financials & Key Ratios
LFMD•NASDAQ
$5.27
$253M mkt cap·Price updated May 6, 2026
AboutLifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.Show more
- Revenue$194M-8.7%
- EBITDA-$361K+94.6%
- Net Income-$7M+62.4%
- EPS (Diluted)-0.23+56.6%
- Gross Margin79.75%-10.1%
- EBITDA Margin-0.19%+94.1%
- Operating Margin-3.95%+48.0%
- Net Margin-3.66%+58.8%
- ROE-74.37%+97.0%
- Debt/Equity0.27
- Interest Coverage-5.64+23.8%
LFMD Key Insights
LifeMD, Inc. (LFMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 34.4%
- ✓Momentum leader: RS Rating 85 (top 15%)
- ✓Strong 5Y sales CAGR of 39.1%
- ✓Efficient asset utilization: 2.8x turnover
✗Weaknesses
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 10.3x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
LFMD Price & Volume
LifeMD, Inc. (LFMD) stock price & volume — 10-year historical chart
Loading chart...
LFMD Growth Metrics
LifeMD, Inc. (LFMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years66.03%
5 Years39.08%
3 Years17.69%
TTM-6.18%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-66.04%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-28.78%
Return on Capital
10 Years-346.01%
5 Years-220.68%
3 Years-96.13%
Last Year-37.37%
LFMD Recent Earnings
LifeMD, Inc. (LFMD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Mar 9, 2026EPS
$0.04
Est $0.01
-300.0%
Revenue
$47M
Est $46M
+2.3%
Q4 2025
Nov 17, 2025EPS
$0.10
Est $0.06
-66.7%
Revenue
$60M
Est $49M
+23.9%
Q3 2025
Aug 5, 2025EPS
$0.05
Est $0.18
-126.0%
Revenue
$62M
Est $66M
-6.2%
Q3 2025
Aug 4, 2025EPS
$0.05
Est $0.18
-126.0%
Revenue
$62M
Est $66M
-6.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 9, 2026 | $0.04vs $0.01-300.0% | $47Mvs $46M+2.3% |
| Q4 2025 | Nov 17, 2025 | $0.10vs $0.06-66.7% | $60Mvs $49M+23.9% |
| Q3 2025 | Aug 5, 2025 | $0.05vs $0.18-126.0% | $62Mvs $66M-6.2% |
| Q3 2025 | Aug 4, 2025 | $0.05vs $0.18-126.0% | $62Mvs $66M-6.2% |
Based on last 12 quarters of dataView full earnings history →
LFMD Peer Comparison
LifeMD, Inc. (LFMD) competitors in Digital Health and Online Pharmacy — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 NUVB | 1.75B | 5.04 | -8.40 | 6.99% | -102.06% | -44.1% | 0.03 | |
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 OPRX | 120.61M | 6.47 | 23.96 | 18.78% | 4.69% | 4.22% | 0.04 | |
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 119.11M | 7.15 | -1.20 | -1.98% | -48.16% | -33.48% | 0.02 | |
 TALK | 869.39M | 5.19 | 129.75 | 22% | 3.4% | 6.89% | ||
 GDRX | 880.73M | 2.57 | 30.13 | 0.57% | 3.74% | 4.75% | 0.10 |
Compare LFMD vs Peers
LifeMD, Inc. (LFMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFMD Income Statement
LifeMD, Inc. (LFMD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 5.05M | 8.32M | 12.47M | 37.29M | 92.88M | 119.03M | 152.55M | 212.45M | 194.06M | 219.42M |
| Revenue Growth % | -3.51% | 64.68% | 49.79% | 199.1% | 149.04% | 28.16% | 28.15% | 39.27% | -8.66% | -6.18% |
| Cost of Goods Sold | 1.48M | 1.97M | 2.53M | 8.86M | 18M | 18.67M | 18.9M | 24.07M | 39.29M | 29.28M |
| COGS % of Revenue | 29.35% | 23.65% | 20.25% | 23.76% | 19.38% | 15.68% | 12.39% | 11.33% | 20.25% | - |
| Gross Profit | 3.57M▲ 0% | 6.36M▲ 78.0% | 9.94M▲ 56.5% | 28.43M▲ 185.9% | 74.88M▲ 163.4% | 100.37M▲ 34.0% | 133.65M▲ 33.2% | 188.39M▲ 41.0% | 154.76M▼ 17.8% | 190.14M▲ 0% |
| Gross Margin % | 70.65% | 76.35% | 79.75% | 76.24% | 80.62% | 84.32% | 87.61% | 88.67% | 79.75% | 86.65% |
| Gross Profit Growth % | 8.46% | 77.96% | 56.46% | 185.95% | 163.36% | 34.03% | 33.16% | 40.96% | -17.85% | - |
| Operating Expenses | 4.64M | 8.41M | 12.83M | 86.25M | 129.18M | 143.81M | 148.14M | 204.53M | 162.43M | 194.93M |
| OpEx % of Revenue | 91.77% | 101.05% | 102.92% | 231.28% | 139.09% | 120.82% | 97.11% | 96.27% | 83.7% | - |
| Selling, General & Admin | 4.64M | 8.41M | 11.31M | 84.01M | 122.08M | 125.33M | 128.15M | 175.68M | 144.01M | 172.43M |
| SG&A % of Revenue | 91.77% | 101.05% | 90.75% | 225.27% | 131.44% | 105.29% | 84% | 82.69% | 74.21% | - |
| Research & Development | 0 | 120.54K | 222.88K | 446.75K | 948.16K | 2.97M | 6.06M | 9.51M | 7.35M | 7.41M |
| R&D % of Revenue | - | 1.45% | 1.79% | 1.2% | 1.02% | 2.5% | 3.97% | 4.48% | 3.79% | - |
| Other Operating Expenses | 0 | -516.98K | 1.3M | 1.79M | 6.16M | 15.51M | 13.93M | 19.34M | 11.07M | 3M |
| Operating Income | -1.07M▲ 0% | -2.06M▼ 92.6% | -2.89M▼ 40.5% | -57.82M▼ 1900.9% | -54.3M▲ 6.1% | -43.45M▲ 20.0% | -14.49M▲ 66.7% | -16.14M▼ 11.4% | -7.67M▲ 52.5% | -12.9M▲ 0% |
| Operating Margin % | -21.12% | -24.7% | -23.18% | -155.04% | -58.47% | -36.5% | -9.5% | -7.6% | -3.95% | -5.88% |
| Operating Income Growth % | 9.12% | -92.61% | -40.54% | -1900.94% | 6.09% | 19.99% | 66.65% | -11.43% | 52.49% | - |
| EBITDA | 160.82K | -1.86M | -2.55M | -57.48M | -53.95M | -42.36M | -7.89M | -6.65M | -361.24K | -5.14M |
| EBITDA Margin % | 3.18% | -22.35% | -20.48% | -154.14% | -58.08% | -35.59% | -5.17% | -3.13% | -0.19% | -2.34% |
| EBITDA Growth % | 114.22% | -1256.79% | -37.28% | -2150.74% | 6.16% | 21.48% | 81.38% | 15.67% | 94.57% | -255.29% |
| D&A (Non-Cash Add-back) | 1.23M | 195.78K | 335.61K | 335.61K | 355.87K | 1.09M | 6.6M | 9.49M | 7.31M | 7.76M |
| EBIT | -1.28M | -2.06M | -2.89M | -57.82M | -54.3M | -39.69M | -14.49M | -16.14M | -7.67M | -5.13M |
| Net Interest Income | -100.52K | -354.39K | -761.15K | -1.67M | -3.02M | -1.28M | -2.6M | -2.18M | -1.36M | -734.69K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 100.52K | 354.39K | 761.15K | 1.67M | 3.02M | 1.28M | 2.6M | 2.18M | 1.36M | 791.17K |
| Other Income/Expense | -150.91K | -354.39K | -761.15K | -2.58M | -7.02M | -1.21M | -2.92M | -2.18M | -2.52M | -2M |
| Pretax Income | -1.22M▲ 0% | -1.48M▼ 21.9% | -3.65M▼ 145.9% | -60.4M▼ 1554.5% | -61.32M▼ 1.5% | -44.66M▲ 27.2% | -17.41M▲ 61.0% | -18.33M▼ 5.3% | -10.19M▲ 44.4% | -14.9M▲ 0% |
| Pretax Margin % | -24.11% | -17.84% | -29.28% | -161.96% | -66.02% | -37.52% | -11.41% | -8.63% | -5.25% | -6.79% |
| Income Tax | -12.49K | -124.7K | -122.5K | 122.5K | 7.7K | 360.7K | 428K | 402K | 45.72K | 959.6K |
| Effective Tax Rate % | 1.02% | 8.4% | 3.36% | -0.2% | -0.01% | -0.81% | -2.46% | -2.19% | -0.45% | -6.44% |
| Net Income | -1.21M▲ 0% | -1.24M▼ 2.9% | -3.14M▼ 152.8% | -58.65M▼ 1769.4% | -60.9M▼ 3.8% | -45.54M▲ 25.2% | -20.6M▲ 54.8% | -18.88M▲ 8.3% | -7.11M▲ 62.4% | -17.03M▲ 0% |
| Net Margin % | -23.86% | -14.91% | -25.16% | -157.26% | -65.57% | -38.25% | -13.5% | -8.89% | -3.66% | -7.76% |
| Net Income Growth % | -8.89% | -2.89% | -152.83% | -1769.4% | -3.84% | 25.23% | 54.77% | 8.32% | 62.36% | -66.04% |
| Net Income (Continuing) | -1.38M | -2.29M | -3.53M | -60.52M | -61.32M | -45.02M | -17.84M | -18.73M | -10.23M | -15.86M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.13M | -409.26K |
| Minority Interest | -259.08K | -77.96K | -141.06K | -2.18M | -1.03M | -475.55K | 2.06M | 1.44M | 0 | 0 |
| EPS (Diluted) | -0.14▲ 0% | -0.14▲ 0.0% | -0.36▼ 157.1% | -4.24▼ 1077.8% | -2.27▲ 46.5% | -1.45▲ 36.1% | -0.70▲ 51.7% | -0.53▲ 24.3% | -0.23▲ 56.6% | -0.36▲ 0% |
| EPS Growth % | 12.5% | 0% | -157.14% | -1077.78% | 46.46% | 36.12% | 51.72% | 24.29% | 56.6% | -28.78% |
| EPS (Basic) | -0.14 | -0.14 | -0.36 | -4.24 | -2.27 | -1.45 | -0.70 | -0.53 | -0.23 | - |
| Diluted Shares Outstanding | 8.8M | 9.05M | 9.9M | 14.28M | 27.01M | 30.98M | 33.91M | 41.2M | 45.13M | 47.34M |
| Basic Shares Outstanding | 8.8M | 8.84M | 9.9M | 14.28M | 27.01M | 30.98M | 33.91M | 41.2M | 45.13M | 47.34M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
LFMD Balance Sheet
LifeMD, Inc. (LFMD) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.26M | 1.61M | 2.75M | 12.41M | 44.92M | 11.31M | 42.6M | 48.73M | 51.83M | 51.7M |
| Cash & Short-Term Investments | 141.38K | 180.09K | 1.11M | 9.18M | 41.33M | 3.96M | 33.15M | 35M | 36.79M | 34.48M |
| Cash Only | 141.38K | 180.09K | 1.11M | 9.18M | 41.33M | 3.96M | 33.15M | 35M | 36.79M | 34.48M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 128.19K | 99.05K | 97.45K | 997.76K | 980.05K | 2.83M | 5.28M | 8.22M | 9.31M | 9.86M |
| Days Sales Outstanding | 9.26 | 4.34 | 2.85 | 9.77 | 3.85 | 8.69 | 12.63 | 14.12 | 17.5 | 14.86 |
| Inventory | 707.16K | 1.02M | 950.06K | 1.26M | 1.62M | 3.7M | 2.76M | 2.8M | 2.77M | 3.18M |
| Days Inventory Outstanding | 173.97 | 189.56 | 137.32 | 52.08 | 32.79 | 72.41 | 53.3 | 42.42 | 25.76 | 39.37 |
| Other Current Assets | 296.48K | 270.01K | 442.97K | 154.88K | 793.19K | 687.02K | 934.51K | 2.67M | 2.97M | 4.19M |
| Total Non-Current Assets | 0 | 1.01M | 699.08K | 990.26K | 5M | 14.35M | 15.88M | 23.73M | 18.58M | 18.43M |
| Property, Plant & Equipment | 0 | 0 | 23.63K | 274.44K | 1.99M | 1.68M | 1.07M | 7.88M | 5.27M | 5.06M |
| Fixed Asset Turnover | - | - | 527.77x | 135.89x | 46.76x | 70.75x | 142.41x | 26.96x | 36.84x | 36.92x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 1.01M | 675.45K | 715.82K | 3.02M | 12.67M | 14.81M | 15.85M | 262.33K | 230.42K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.05M | 43.95M |
| Total Assets | 1.26M▲ 0% | 2.62M▲ 107.0% | 3.45M▲ 31.7% | 13.4M▲ 288.9% | 49.92M▲ 272.5% | 25.67M▼ 48.6% | 58.48M▲ 127.9% | 72.46M▲ 23.9% | 70.41M▼ 2.8% | 70.12M▲ 0% |
| Asset Turnover | 4.00x | 3.18x | 3.62x | 2.78x | 1.86x | 4.64x | 2.61x | 2.93x | 2.76x | 3.13x |
| Asset Growth % | 60.01% | 107% | 31.73% | 288.92% | 272.48% | -48.59% | 127.85% | 23.9% | -2.83% | -1.36% |
| Total Current Liabilities | 640.97K | 1.19M | 3.98M | 13.93M | 22.83M | 31.37M | 34.78M | 60.26M | 41.57M | 49.59M |
| Accounts Payable | 473.49K | 869K | 3M | 10.41M | 9.06M | 10.11M | 11.08M | 16.01M | 14.15M | 21.65M |
| Days Payables Outstanding | 116.48 | 161.08 | 433.34 | 428.72 | 183.75 | 197.61 | 214.07 | 242.78 | 131.43 | 248.2 |
| Short-Term Debt | 167.48K | 247.42K | 814.73K | 779.13K | 63.4K | 2.8M | 327.6K | 8.44M | 642.42K | 670.83K |
| Deferred Revenue (Current) | -473.49K | 75.98K | 0 | 916.88K | 1.5M | 5.55M | 8.83M | 14.48M | 10.81M | 48.97M |
| Other Current Liabilities | -422.35K | -869K | 109.55K | 237.04K | 1.66M | 576.03K | 10.93M | 5.11M | 15.97M | 36.9M |
| Current Ratio | 1.97x | 1.35x | 0.69x | 0.89x | 1.97x | 0.36x | 1.22x | 0.81x | 1.25x | 1.25x |
| Quick Ratio | 0.87x | 0.49x | 0.45x | 0.80x | 1.90x | 0.24x | 1.15x | 0.76x | 1.18x | 1.18x |
| Cash Conversion Cycle | 66.74 | 32.82 | -293.17 | -366.88 | -147.11 | -116.51 | -148.14 | -186.24 | -88.16 | -193.97 |
| Total Non-Current Liabilities | 0 | 604K | 599.98K | 292.32K | 1.28M | 1.6M | 18.13M | 16.25M | 5.68M | 5.5M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 17.93M | 9.89M | 0 | 5.5M |
| Capital Lease Obligations | 0 | 0 | 29.98K | 192.32K | 1.18M | 574.14K | 73.85K | 6.27M | 5.68M | 17.57M |
| Deferred Tax Liabilities | 0 | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 600K | 570K | 100K | 100K | 1.02M | 131.25K | 100K | 0 | 200K |
| Total Liabilities | 640.97K | 1.8M | 4.58M | 14.22M | 24.1M | 32.97M | 52.91M | 76.51M | 47.25M | 55.09M |
| Total Debt | 167.48K | 247.42K | 844.71K | 1.06M | 1.85M | 4.13M | 18.93M | 25.1M | 6.32M | 6.17M |
| Net Debt | 26.1K | 67.32K | -261.91K | -8.11M | -39.48M | 168.52K | -14.21M | -9.9M | -30.46M | -28.31M |
| Debt / Equity | 0.27x | 0.30x | - | - | 0.07x | - | 3.40x | - | 0.27x | 0.27x |
| Debt / EBITDA | 1.04x | - | - | - | - | - | - | - | - | -1.20x |
| Net Debt / EBITDA | 0.16x | - | - | - | - | - | - | - | - | 5.51x |
| Interest Coverage | -12.72x | -5.80x | -3.80x | -34.67x | -17.98x | -31.10x | -5.58x | -7.40x | -5.64x | -6.48x |
| Total Equity | 622.84K▲ 0% | 819.74K▲ 31.6% | -1.13M▼ 237.8% | -821.76K▲ 27.2% | 25.82M▲ 3241.9% | -7.31M▼ 128.3% | 5.57M▲ 176.2% | -4.05M▼ 172.7% | 23.16M▲ 672.4% | 15.04M▲ 0% |
| Equity Growth % | 272.19% | 31.61% | -237.76% | 27.23% | 3241.91% | -128.29% | 176.19% | -172.68% | 672.42% | 4876.11% |
| Book Value per Share | 0.07 | 0.09 | -0.11 | -0.06 | 0.96 | -0.24 | 0.16 | -0.10 | 0.51 | 0.32 |
| Total Shareholders' Equity | 881.92K | 897.7K | -988.18K | 1.35M | 26.85M | -6.83M | 3.51M | -5.49M | 23.16M | 15.04M |
| Common Stock | 444.93K | 457.82K | 106.81K | 234.34K | 307.05K | 315.53K | 383.59K | 422.94K | 467.6K | 476.33K |
| Retained Earnings | -10.9M | -12.14M | -16.59M | -80.15M | -141.92M | -190.56M | -214.27M | -236.25M | -228.6M | -238.25M |
| Treasury Stock | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -259.08K | -77.96K | -141.06K | -2.18M | -1.03M | -475.55K | 2.06M | 1.44M | 0 | 0 |
LFMD Cash Flow Statement
LifeMD, Inc. (LFMD) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -817.22K | -905.52K | 251.41K | -12.13M | -33.09M | -22.94M | 8.82M | 17.51M | 8.28M | 8.28M |
| Operating CF Margin % | -16.17% | -10.88% | 2.02% | -32.53% | -35.62% | -19.27% | 5.78% | 8.24% | 4.27% | - |
| Operating CF Growth % | -100.34% | -10.81% | 127.76% | -4925.47% | -172.72% | 30.68% | 138.46% | 98.56% | -52.72% | -406.75% |
| Net Income | -1.21M | -1.36M | -3.53M | -60.52M | -61.32M | -45.02M | -20.6M | -18.73M | 15.62M | -17.03M |
| Depreciation & Amortization | 91.56K | 195.78K | 335.61K | 397.76K | 868.76K | 3.77M | 6.6M | 9.49M | 328.37K | -3.05M |
| Stock-Based Compensation | 162.74K | 273.57K | 733.22K | 18.66M | 12.07M | 13.73M | 12.49M | 12.23M | 10.5M | 9.4M |
| Deferred Taxes | -90.28K | 4K | 66K | 914.86K | 0 | 354K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 918.01K | 237.2K | 578.61K | 19.63M | 6.17M | 5.78M | 5.42M | 1.87M | -10.31M | -441.69K |
| Working Capital Changes | -693.28K | -255.97K | 2.07M | 8.8M | 9.13M | -1.55M | 4.91M | 12.65M | -7.85M | -759.98K |
| Change in Receivables | 95.09K | 29.14K | 1.6K | -550.97K | 17.7K | -2.19M | -2.44M | -2.94M | 1.15M | 2.58M |
| Change in Inventory | -546.89K | -341.36K | 72.56K | -314.2K | -409.82K | -2.18M | 764.33K | 675.67K | 303.24K | 399.77K |
| Change in Payables | -227.23K | 6.34K | 1.89M | 8.93M | -893.96K | 1.25M | 978.06K | 4.92M | 3.24M | 11.08M |
| Cash from Investing | 63.38K | 141.44K | -100K | -798.14K | -3.4M | -13.91M | -8.73M | -11.54M | 6.91M | 7.72M |
| Capital Expenditures | 0 | -100K | 0 | -398.14K | -247.37K | -366.63K | -203.81K | -1.49M | 0 | 1.04M |
| CapEx % of Revenue | - | 1.2% | - | 1.07% | 0.27% | 0.31% | 0.13% | 0.7% | 0.96% | - |
| Acquisitions | 63.38K | 241.44K | -100K | -400K | 0 | -1.01M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 290K | -100K | 0 | -3.15M | -12.53M | -8.53M | -10.05M | 6.91M | 6.68M |
| Cash from Financing | 776.03K | 802.79K | 775.12K | 21M | 68.64M | -528.2K | 29.1M | -4.12M | -13.41M | -13.29M |
| Debt Issued (Net) | 116.06K | 642.44K | 798.28K | 93.19K | -530.82K | 2.74M | 16.67M | -327.6K | -18.72M | -18.72M |
| Equity Issued (Net) | 596.6K | 0 | 350K | 20.13M | 69.33M | 0 | 16.2M | 0 | 9.19M | 9.19M |
| Dividends Paid | 0 | 0 | 0 | -1.29M | -871.48K | -3.11M | -3.11M | -3.11M | -3.11M | -3.11M |
| Share Repurchases | -76.65K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 63.38K | 160.35K | -373.15K | 2.07M | 707.36K | -159.2K | -667.63K | -684.83K | -773.66K | -657.14K |
| Net Change in Cash | -41.18K▲ 0% | 38.71K▲ 194.0% | 926.53K▲ 2293.3% | 8.07M▲ 771.3% | 32.15M▲ 298.3% | -37.37M▼ 216.2% | 29.19M▲ 178.1% | 1.86M▼ 93.6% | 1.78M▼ 4.1% | 84.73K▲ 0% |
| Free Cash Flow | -817.22K▲ 0% | -1.01M▼ 23.0% | 251.41K▲ 125.0% | -12.53M▼ 5083.8% | -36.49M▼ 191.2% | -35.83M▲ 1.8% | 86.95K▲ 100.2% | 5.98M▲ 6774.1% | 6.41M▲ 7.2% | 14.94M▲ 0% |
| FCF Margin % | -16.17% | -12.08% | 2.02% | -33.6% | -39.29% | -30.1% | 0.06% | 2.81% | 3.3% | 6.81% |
| FCF Growth % | -100.34% | -23.04% | 125% | -5083.83% | -191.21% | 1.81% | 100.24% | 6774.08% | 7.24% | 371.73% |
| FCF per Share | -0.09 | -0.11 | 0.03 | -0.88 | -1.35 | -1.16 | 0.00 | 0.15 | 0.14 | 0.14 |
| FCF Conversion (FCF/Net Income) | 0.68x | 0.73x | -0.08x | 0.21x | 0.54x | 0.50x | -0.43x | -0.93x | -1.17x | -0.88x |
| Interest Paid | 0 | 0 | 0 | 0 | 435.05K | 189K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LFMD Key Ratios
LifeMD, Inc. (LFMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -923.7% | -172.03% | - | - | -487.23% | -491.92% | -370.02% | -2483.15% | -74.37% | -162.38% |
| Return on Invested Capital (ROIC) | -514.86% | -200.79% | - | - | - | - | - | - | - | 80.21% |
| Gross Margin | 70.65% | 76.35% | 79.75% | 76.24% | 80.62% | 84.32% | 87.61% | 88.67% | 79.75% | 86.65% |
| Net Margin | -23.86% | -14.91% | -25.16% | -157.26% | -65.57% | -38.25% | -13.5% | -8.89% | -3.66% | -7.76% |
| Debt / Equity | 0.27x | 0.30x | - | - | 0.07x | - | 3.40x | - | 0.27x | 0.27x |
| Interest Coverage | -12.72x | -5.80x | -3.80x | -34.67x | -17.98x | -31.10x | -5.58x | -7.40x | -5.64x | -6.48x |
| FCF Conversion | 0.68x | 0.73x | -0.08x | 0.21x | 0.54x | 0.50x | -0.43x | -0.93x | -1.17x | -0.88x |
| Revenue Growth | -3.51% | 64.68% | 49.79% | 199.1% | 149.04% | 28.16% | 28.15% | 39.27% | -8.66% | -6.18% |
LFMD SEC Filings & Documents
LifeMD, Inc. (LFMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
LFMD Frequently Asked Questions
LifeMD, Inc. (LFMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
LifeMD, Inc. (LFMD) reported $219.4M in revenue for fiscal year 2025. This represents a 29399% increase from $0.7M in 2011.
LifeMD, Inc. (LFMD) saw revenue decline by 8.7% over the past year.
LifeMD, Inc. (LFMD) reported a net loss of $17.0M for fiscal year 2025.
Dividend & Returns
Yes, LifeMD, Inc. (LFMD) pays a dividend with a yield of 1.31%. This makes it attractive for income-focused investors.
LifeMD, Inc. (LFMD) has a return on equity (ROE) of -74.4%. Negative ROE indicates the company is unprofitable.
LifeMD, Inc. (LFMD) generated $14.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More LFMD
LifeMD, Inc. (LFMD) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates